Gerloni M, Xiong S, Mukerjee S, Schoenberger S P, Croft M, Zanetti M
The Department of Medicine and Cancer Center, University of California at San Diego, La Jolla CA 92093-0368, USA.
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13269-74. doi: 10.1073/pnas.230429197.
The immune response to T helper (Th) cell determinants of a variety of antigens is often poor and limits severely the potential efficacy of current therapeutic measures through vaccination. Here, we report that an immunologically silent tumor determinant can be rendered immunogenic if linked with a dominant determinant of a parasite antigen, suggesting the existence of functional Th-Th cooperation in vivo. This phenomenon could be mimicked in part by signaling either through CD40 to the antigen-presenting cells or through OX40 to the tumor-determinant reactive T cells, with maximal effects obtained by combined anti-CD40 and anti-OX40 treatment in vivo. The data suggest that CD4 T cells reactive with a dominant determinant provide help to other CD4 T cells through up-regulating the costimulatory ability of antigen-presenting cells, in much the same way as help for CD8 cells. CD4 help for CD4 T cells represents a new immunological principle and offers new practical solutions for vaccine therapy against cancer and other diseases in which antigenic help is limiting.
针对多种抗原的辅助性T(Th)细胞决定簇的免疫反应通常较弱,这严重限制了当前通过疫苗接种进行治疗的潜在疗效。在此,我们报告,如果与寄生虫抗原的显性决定簇相连,免疫沉默的肿瘤决定簇可变得具有免疫原性,这表明体内存在功能性的Th-Th协作。通过向抗原呈递细胞传递CD40信号或向肿瘤决定簇反应性T细胞传递OX40信号,可部分模拟这一现象,在体内联合使用抗CD40和抗OX40治疗可获得最大效果。数据表明,与显性决定簇反应的CD4 T细胞通过上调抗原呈递细胞的共刺激能力为其他CD4 T细胞提供帮助,其方式与对CD8细胞的帮助非常相似。CD4对CD4 T细胞的帮助代表了一种新的免疫学原理,并为针对癌症和其他抗原性帮助受限疾病的疫苗治疗提供了新的实际解决方案。